Health
Trimetazidine does not improve outcomes in patients with chronic or acute coronary syndromes – News-Medical.Net
Trimetazidine administered after successful percutaneous coronary intervention (PCI) does not improve outcomes in patients with chronic or acute coronary syndromes, according to results of the ATPCI trial presented in a Hot Line session today at ESC Congress …
Trimetazidine administered after successful percutaneous coronary intervention (PCI) does not improve outcomes in patients with chronic or acute coronary syndromes, according to results of the ATPCI trial presented in a Hot Line session today at ESC Congress 2020.
Angina refers to constricting pain or discomfort in the front of the chest or in the neck, jaw, shoulder, or arm due to reduced blood flow to the heart. It can occur during acute coronary syndromes (ACS) and chronic coronary syndromes…
-
General21 hours agoEmergency services winch man to safety in Great Ocean Road cliff rescue
-
General24 hours agoTaxpayers to pay Pauline Hanson’s PHON $3m for no seats
-
General14 hours agoGetting COVID booster alongside flu shot could reduce hospitalisations, study finds
-
General20 hours agoAbbott, Howard, and Menzies mean nothing to the young